NCT04181463View on ClinicalTrials.gov

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

November 5, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Malignant Neoplasm
Interventions
DRUG

Isopropyl Alcohol

Given via nasal inhalation

OTHER

Placebo

Given via nasal inhalation

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER